Investor
The startup said its Care Pathway Management platform has so far been deployed among more than 70 health systems in 12 countries.
Cerner's investment into Xealth brings digital health prescription tools to its EHR & patient portal
The Providence-St. Joseph Health spin-out will receive $6 million from Cerner and LRVHealth.
The MobiHealthNews team breaks down the week's big digital health news: Teladoc's proposed $18 billion acquisition of Livongo.
Also: Dexcom continues to make strides, while iRhythm Technologies takes a hit in Q2.
The new round was led by European Bank for Reconstruction and Development and Health Capital.
The company said its services are accessible to millions of people through partnerships with over 200 employers, health plans and other strategic partners.
The deal is valued at roughly $4.7 billion.
The company's complete blood count analyzer uses artificial intelligence to quickly measure biomarkers from a fingerstick or venous sample.
Each Livongo share will be converted Teladoc stock at a 0.5920 exchange rate, plus an additional $11.44 in cash per stock.
The listing could happen either later this year or in early 2021, Reuters reports.